Postdoctoral Researcher
Ghent University & KULeuven

Niels was awarded a prestigious fellowship from the Belgian American Educational Foundation (BAEF) to start his own research project at an American University in continuation of his veterinary medicine studies. Niels moved to the USA in 2019 to start his PhD at the Institute for Bioscience and Biotechnology Research, associated to the University of Maryland, where he focused on investigating bacteriophage-derived enzymes (endolysins) as promising novel antimicrobials for bovine mastitis. Upon termination of his one-year doctoral research stay in the USA, Niels successfully received additional personal funding from Research Foundation Flanders (FWO) to finish his interdisciplinary PhD project as an interuniversity collaboration between the groups of Prof. dr. Rob Lavigne (KULeuven), Prof. dr. Yves Briers (UGent) and Prof. dr. Evelyne Meyer (UGent). During his FWO mandate from 2020 to 2023, Niels contributed to international conferences, published several first-authored manuscripts and managed to file two patents, one full patent in Europe and one provisional patent in the USA. The latter was selected as finalist for the ‘Invention of the Year’ award by the University of Maryland. Niels has tutored multiple veterinary students as well as junior PhD students, which resulted in the start of two new endolysin-related projects at UGent by acquiring more funding. Niels has recently received a postdoctoral scholarship from the Swedish 'Kronprinsessan Lovisas Förening För Barnasjukvård / Stiftelsen Axel Tielmans Minnesfond' to proceed with his academic career in the team of Prof. dr. Federico Iovino at the Karolinska Institute in Stockholm, Sweden. Niels continues to engineer endolysins, now aiming to tackle pneumococcal meningitis in children and newborns.


Other speakers

Emmanuel Hanon CEO Vicebio
Sven Arnouts Business Development Manager Ghent University - Provaxs
Lourdes Mottier Head of Business Development Strategy Elanco Animal Health
Hans Nauwynck - Panelist Professor University of Ghent
Michael Hemprich - Moderator
Stefaan Wera Chief Operating Officer/Co-founder Virovet
Joris Vandeputte - Moderator President and Founder VacciM
Lauren Carde - Moderator V.P. Operations and Regulatory Affairs Paul Dick and Associates
Klaus Hellmann - Moderator Chief Veterinary Officer Argenta
Vladimir Pucovsky Scientific Administrator EMA Europa
Jose Carlos Mancera - panelist Senior Clinical Manager Zoetis
Liesbeth Ceelen - Moderator CEO BioLizard
Stein Aerts - panelist Scientific Director & Group Leader VIB
Daniel Jameson - panelist CEO Biorelate
Johannes Charlier Managing Director Kreavet
Jan Wauters Science & Technology Counselor Flanders Investment & Trade
Roxane Feller Secretary General Animal Health Europe
Hans Van Der Weken Postdoctoral Researcher Ghent University
Jeroen De Buck Professor Veterinary Microbiology University of Calgary
Kathleen Marchal Professor Bioinformatics University of Ghent
Paul Hodgson Director of Operations VIDO
Nathalie Vanderheijden Coordinator fot the EUP AH&W University of Ghent
Ann Martens Dean of the Faculty of Veterinary Medicine Ghent University
Lionel Malbec Product Manager Quantoom Biosciences
Lucas Decuypere CEO Allegro
Jelena Suran CEO Apiotix Technologies
Paul Dick Founder and President Paul Dick and Associates
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer-Ingelheim Animal Health
Eduardo Pontes Associate Director Research Alliances (EU) - External Innovation Zoetis
Filip Goossens Senior Investment Manager PMV
Sanjay Vashee Professor and Rockville Campus Director J. Craig Venter Institute
Lucy Davidson Professor of Veterinary Clinical Genetics and MRC Clinician Scientist Fellow Royal Veterinary College
Charles Owen CEO 272BIO
Annelies Bogaerts CDO Benno Therapeutics
Andrea Mariani CEO Soundsafe Care
Thomas Demeester Assistant Professor University of Ghent
Matthias Hofer Managing Partner SC Group (Stonehaven Cozmix Group AG)
Mathieu Peyrou Global Pharmaceuticals Development Director CEVA
Steve Nanchen Head external innovation Elanco

Interested? Register now!

Register here